ArticleFrontiers in medicine2026
Multicenter evaluation of a digital screening tool for early identification of temporomandibular disorder risk in Colombian and Mexican adults.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the performance, applicability, and real-world utility of a validated digital screening tool for early identification of temporomandibular disorder (TMD) risk in Colombian and Mexican adults. Methods: A cross-sectional, multicenter study included 429 adults (299 Mexico, 130 Colombia) who completed a standardized digital application assessing joint pain, bruxism, mandibular locking, joint sounds, parafunctional habits, trauma history, and emotional factors. TMD risk was classified using a composite digital score into low, moderate, or high categories, emphasizing that the tool measures participants' risk classification and internal construct consistency rather than population prevalence or causal risk factors. Descriptive statistics (mean ± SD, frequencies %) and effect sizes (Cohen's d, Cramér's V) were calculated. Logistic regression identified independent predictors of high TMD risk. Results: Mean age was 29.9 ± 13.3 years in Mexico and 28.8 ± 10.8 in Colombia ( Conclusion: The digital screening tool effectively stratified TMD risk in a multicenter, real-world setting, highlighting its potential for early identification, population-based screening, and clinical implementation in diverse Latin American populations. Indicators classified as high-risk were observed more frequently among women and younger adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.